|
- DCVC | Home
For 15 years, DCVC has backed brilliant entrepreneurs who address the hardest, highest-stakes problems in the world
- Team - DCVC
Team DCVC is devoted to earning venture-scale returns for our investors by backing companies using deep tech to solve the hardest problems in the world Our scientifically literate partners come from and operate in the networks that matter most for our companies 01 05
- Companies - DCVC
Data Collective backs companies using deep tech to solve the biggest problems that matter Our investments address climate change, human health, the…
- DCVC | DCVC Bio
Our investment team members are experts in genetics, chemistry, molecular biology, agriculture, industrial fermentation, AI, and more In making and supporting our investments from DCVC Bio’s funds, we combine scientific acumen with the wisdom gained from decades of operational management
- About - DCVC
DCVC is deep tech venture capital It always has been Over more than a dozen years, we’ve backed brilliant entrepreneurs using computational approaches to solve trillion-dollar problems in the real world across a broad set of industries, especially those that haven’t seen material progress in decades
- DCVC closes $700 million+ in new funds for a healthier planet and…
DCVC closes $ 700 million+ in new funds for a healthier planet and healthier lives; releases second-annual Deep Tech Opportunities Report and first-annual DCVC Climate Impact Report Our first dedicated Climate fund and newest DCVC Bio fund are putting deep tech to work 30 Sep 2024 Climate, Computational Bio Chem, Smart Agriculture
- DCVC Deep Tech Opportunities Report 2025
We are deep tech venture capital Our third annual Deep Tech Opportunities Report explains the guiding principles behind our investing and outlines the areas we’re most excited about right now This year, we focused on the prospect of an American industrial renaissance: we see great opportunity in revitalizing domestic manufacturing and supply chains; ensuring that our energy
- DCVC | News Insights
Proxima raises $80M in seed financing, led by DCVC, to reprogram protein-protein interactions By Jason Pontin 13 Jan 2026 View All News Insights
|
|
|